Gene Symbol | Gene ID | Gene Info |
---|---|---|
Obox6
|
ENSMUSG00000041583.7 | oocyte specific homeobox 6 |
Obox5
|
ENSMUSG00000074366.3 | oocyte specific homeobox 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Obox5 | mm10_chr7_16174987_16175264 | 0.87 | 1.6e-17 | Click! |
Obox6 | mm10_chr7_16221662_16222350 | -0.27 | 4.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_99516425_99517155 | 15.61 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr2_94246412_94247550 | 15.26 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr16_33605736_33606716 | 15.12 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr16_77291582_77292053 | 11.32 |
Gm31258 |
predicted gene, 31258 |
13743 |
0.19 |
chr13_83727309_83727854 | 11.31 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr18_45896851_45897467 | 11.08 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr12_90132535_90132958 | 10.88 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr3_17793898_17794135 | 10.58 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
71 |
0.96 |
chr16_67611348_67611518 | 10.28 |
Cadm2 |
cell adhesion molecule 2 |
9060 |
0.25 |
chr14_21411188_21411393 | 9.96 |
Gm25864 |
predicted gene, 25864 |
39184 |
0.14 |
chr15_85464224_85464612 | 9.66 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
38809 |
0.14 |
chr3_88206531_88206915 | 9.53 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chr14_34969154_34969501 | 9.30 |
Mir346 |
microRNA 346 |
74718 |
0.11 |
chr6_136172482_136172648 | 9.12 |
Gm26653 |
predicted gene, 26653 |
496 |
0.51 |
chr10_22609004_22609241 | 9.09 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35889 |
0.16 |
chr6_112809545_112809826 | 9.08 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chrX_13346707_13347908 | 9.05 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr1_70442796_70442968 | 9.04 |
Gm38272 |
predicted gene, 38272 |
129971 |
0.05 |
chr2_53437127_53437348 | 9.01 |
Gm13501 |
predicted gene 13501 |
38750 |
0.2 |
chr2_50971005_50971315 | 8.89 |
Gm13498 |
predicted gene 13498 |
61476 |
0.15 |
chr2_34107471_34107667 | 8.87 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
160 |
0.96 |
chr2_136712228_136712733 | 8.72 |
Snap25 |
synaptosomal-associated protein 25 |
973 |
0.59 |
chr2_62341685_62342124 | 8.70 |
Dpp4 |
dipeptidylpeptidase 4 |
3242 |
0.24 |
chr2_134929542_134929848 | 8.54 |
Gm14036 |
predicted gene 14036 |
125746 |
0.05 |
chr2_21283000_21283174 | 8.25 |
Gm13378 |
predicted gene 13378 |
38982 |
0.15 |
chr1_98190040_98190483 | 8.21 |
Gm29461 |
predicted gene 29461 |
16613 |
0.2 |
chr6_28980766_28981191 | 8.16 |
Gm3294 |
predicted gene 3294 |
656 |
0.73 |
chr4_138505186_138505392 | 8.06 |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
50975 |
0.1 |
chr15_91017743_91018222 | 8.00 |
Kif21a |
kinesin family member 21A |
31836 |
0.16 |
chr9_99994460_99994673 | 8.00 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
27734 |
0.17 |
chr1_33494905_33495073 | 8.00 |
Gm29228 |
predicted gene 29228 |
12888 |
0.21 |
chr14_86063145_86063329 | 7.98 |
Gm32729 |
predicted gene, 32729 |
109686 |
0.06 |
chr8_90536467_90536639 | 7.89 |
Gm45639 |
predicted gene 45639 |
138405 |
0.04 |
chr6_144313023_144313448 | 7.88 |
Sox5 |
SRY (sex determining region Y)-box 5 |
103667 |
0.08 |
chrX_143518693_143518904 | 7.85 |
Pak3 |
p21 (RAC1) activated kinase 3 |
100 |
0.98 |
chr4_154948580_154948853 | 7.85 |
Hes5 |
hes family bHLH transcription factor 5 |
12207 |
0.11 |
chr13_90089017_90089768 | 7.79 |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
131 |
0.69 |
chr1_81520769_81521201 | 7.79 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr13_72029205_72029633 | 7.78 |
Irx1 |
Iroquois homeobox 1 |
65696 |
0.13 |
chr5_3543360_3543583 | 7.78 |
Fam133b |
family with sequence similarity 133, member B |
362 |
0.58 |
chr1_126865904_126866078 | 7.77 |
4930599A14Rik |
RIKEN cDNA 4930599A14 gene |
10598 |
0.26 |
chr6_93913318_93913558 | 7.76 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
116 |
0.98 |
chr4_21689447_21689958 | 7.75 |
Prdm13 |
PR domain containing 13 |
3739 |
0.21 |
chr2_6884852_6885717 | 7.75 |
Celf2 |
CUGBP, Elav-like family member 2 |
288 |
0.83 |
chr3_55756852_55757100 | 7.70 |
Mab21l1 |
mab-21-like 1 |
25534 |
0.18 |
chr2_41669936_41670198 | 7.69 |
Lrp1b |
low density lipoprotein-related protein 1B |
119011 |
0.07 |
chr1_69023473_69023624 | 7.68 |
Gm16076 |
predicted gene 16076 |
83192 |
0.09 |
chr11_78786013_78786424 | 7.55 |
Gm23840 |
predicted gene, 23840 |
31696 |
0.11 |
chrX_22849813_22849966 | 7.54 |
Gm26131 |
predicted gene, 26131 |
12047 |
0.31 |
chr7_73399870_73400476 | 7.46 |
Gm44758 |
predicted gene 44758 |
4177 |
0.15 |
chrX_61154776_61154939 | 7.35 |
Gm24396 |
predicted gene, 24396 |
9495 |
0.16 |
chr10_103726584_103727032 | 7.35 |
Gm47224 |
predicted gene, 47224 |
131524 |
0.04 |
chr12_35896011_35896516 | 7.34 |
Agr3 |
anterior gradient 3 |
29357 |
0.17 |
chr16_43464263_43464471 | 7.34 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
39247 |
0.15 |
chr3_159885217_159885703 | 7.27 |
Gm43307 |
predicted gene 43307 |
9614 |
0.23 |
chr1_82261760_82261911 | 7.26 |
Gm9747 |
predicted gene 9747 |
28723 |
0.15 |
chr1_131770683_131771116 | 7.23 |
Slc26a9 |
solute carrier family 26, member 9 |
20408 |
0.14 |
chr14_64533719_64533870 | 7.20 |
Gm47202 |
predicted gene, 47202 |
3744 |
0.24 |
chr4_55077601_55077829 | 7.17 |
Gm12515 |
predicted gene 12515 |
38848 |
0.15 |
chr12_29368101_29368299 | 7.15 |
Gm6989 |
predicted gene 6989 |
50632 |
0.17 |
chr9_37001994_37002204 | 7.13 |
Gm3896 |
predicted gene 3896 |
13659 |
0.15 |
chr13_107767262_107767617 | 7.10 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr13_28415819_28416047 | 7.10 |
Gm40841 |
predicted gene, 40841 |
3930 |
0.29 |
chr9_4795256_4795420 | 7.05 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
181 |
0.97 |
chr18_13305376_13305843 | 7.04 |
Gm41669 |
predicted gene, 41669 |
729 |
0.75 |
chr17_6860510_6860926 | 7.02 |
Mir692-1 |
microRNA 692-1 |
34619 |
0.11 |
chr2_151631930_151632148 | 7.01 |
Snph |
syntaphilin |
432 |
0.78 |
chr2_62048238_62048412 | 7.00 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
1680 |
0.49 |
chr4_74013078_74013818 | 6.99 |
Frmd3 |
FERM domain containing 3 |
4 |
0.98 |
chr17_70633313_70633464 | 6.93 |
Dlgap1 |
DLG associated protein 1 |
71836 |
0.11 |
chr14_66344453_66344629 | 6.93 |
Stmn4 |
stathmin-like 4 |
160 |
0.95 |
chr1_173389363_173389746 | 6.93 |
Cadm3 |
cell adhesion molecule 3 |
21859 |
0.15 |
chr15_8815380_8815535 | 6.92 |
Gm5043 |
predicted gene 5043 |
99027 |
0.07 |
chr16_77236770_77236921 | 6.89 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
526 |
0.83 |
chr2_145859511_145860521 | 6.87 |
Rin2 |
Ras and Rab interactor 2 |
2628 |
0.24 |
chr13_81628689_81629170 | 6.86 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
4210 |
0.23 |
chr2_79399771_79399935 | 6.82 |
Cerkl |
ceramide kinase-like |
6819 |
0.22 |
chr8_8232331_8232493 | 6.82 |
A630009H07Rik |
RIKEN cDNA A630009H07 gene |
102665 |
0.06 |
chr6_86051794_86051956 | 6.78 |
Add2 |
adducin 2 (beta) |
373 |
0.79 |
chr15_25753970_25754154 | 6.77 |
Myo10 |
myosin X |
1083 |
0.59 |
chr16_63856960_63857870 | 6.76 |
Epha3 |
Eph receptor A3 |
5998 |
0.31 |
chr7_130977605_130978173 | 6.73 |
Htra1 |
HtrA serine peptidase 1 |
3781 |
0.24 |
chr5_14834201_14834402 | 6.72 |
Gm43665 |
predicted gene 43665 |
29400 |
0.17 |
chr3_39047740_39047911 | 6.70 |
Gm43539 |
predicted gene 43539 |
38144 |
0.19 |
chr7_141946026_141946417 | 6.70 |
Gm20501 |
predicted gene 20501 |
108 |
0.95 |
chr13_72298631_72298782 | 6.68 |
Gm4052 |
predicted gene 4052 |
51515 |
0.15 |
chr16_44579610_44579783 | 6.68 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
20799 |
0.19 |
chr9_78880202_78880613 | 6.65 |
Gm47498 |
predicted gene, 47498 |
56376 |
0.1 |
chr13_29273638_29274140 | 6.64 |
Gm11364 |
predicted gene 11364 |
37269 |
0.22 |
chr18_16561397_16561575 | 6.64 |
Cdh2 |
cadherin 2 |
108583 |
0.07 |
chr2_69722464_69722689 | 6.63 |
Ppig |
peptidyl-prolyl isomerase G (cyclophilin G) |
31 |
0.96 |
chr4_87651182_87651681 | 6.58 |
Gm12604 |
predicted gene 12604 |
70642 |
0.13 |
chr1_132591364_132591989 | 6.58 |
Nfasc |
neurofascin |
4536 |
0.23 |
chr2_57375525_57375823 | 6.57 |
Gm13531 |
predicted gene 13531 |
50035 |
0.15 |
chr12_7029729_7029880 | 6.56 |
Gm46311 |
predicted gene, 46311 |
62844 |
0.16 |
chr2_80129445_80129882 | 6.55 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
205 |
0.94 |
chr3_79417407_79417581 | 6.55 |
Fnip2 |
folliculin interacting protein 2 |
48711 |
0.13 |
chr19_28337285_28337436 | 6.51 |
Glis3 |
GLIS family zinc finger 3 |
11354 |
0.29 |
chr6_112820468_112820619 | 6.48 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
8916 |
0.23 |
chr2_91399403_91399554 | 6.46 |
Gm22071 |
predicted gene, 22071 |
7658 |
0.17 |
chr7_16174987_16175264 | 6.45 |
Meis3 |
Meis homeobox 3 |
14 |
0.96 |
chrX_152656185_152656553 | 6.45 |
Shroom2 |
shroom family member 2 |
11826 |
0.22 |
chr17_68836555_68836987 | 6.45 |
Tmem200c |
transmembrane protein 200C |
365 |
0.55 |
chr1_43754641_43754969 | 6.45 |
Gm29156 |
predicted gene 29156 |
8523 |
0.13 |
chr7_54782042_54782216 | 6.43 |
Luzp2 |
leucine zipper protein 2 |
53369 |
0.15 |
chr9_108460151_108461186 | 6.42 |
Ccdc71 |
coiled-coil domain containing 71 |
133 |
0.64 |
chr13_84062212_84062522 | 6.41 |
Gm17750 |
predicted gene, 17750 |
2405 |
0.33 |
chr7_49699439_49699606 | 6.38 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59593 |
0.11 |
chr1_76490736_76491111 | 6.37 |
Gm17751 |
predicted gene, 17751 |
1790 |
0.42 |
chr18_76161215_76161703 | 6.36 |
Mir6358 |
microRNA 6358 |
9093 |
0.21 |
chr13_84059669_84060031 | 6.36 |
Gm17750 |
predicted gene, 17750 |
4922 |
0.24 |
chr8_49243134_49243285 | 6.35 |
Gm45832 |
predicted gene 45832 |
11240 |
0.28 |
chr4_85162843_85163021 | 6.27 |
Gm12417 |
predicted gene 12417 |
13595 |
0.22 |
chr16_69469147_69469298 | 6.26 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
331159 |
0.01 |
chr5_135725743_135726117 | 6.26 |
Por |
P450 (cytochrome) oxidoreductase |
202 |
0.89 |
chr5_66917796_66917995 | 6.26 |
Gm43281 |
predicted gene 43281 |
1887 |
0.28 |
chr13_23949986_23950148 | 6.26 |
Scgn |
secretagogin, EF-hand calcium binding protein |
5512 |
0.1 |
chr4_97582844_97583029 | 6.25 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1660 |
0.43 |
chr7_51749650_51749828 | 6.25 |
Gm7336 |
predicted gene 7336 |
3092 |
0.24 |
chr18_83949927_83950078 | 6.22 |
Gm50421 |
predicted gene, 50421 |
37993 |
0.16 |
chr2_146724257_146724438 | 6.21 |
Gm14111 |
predicted gene 14111 |
31358 |
0.22 |
chr14_24827598_24827976 | 6.21 |
Gm47906 |
predicted gene, 47906 |
5848 |
0.28 |
chr2_37931114_37931298 | 6.19 |
Dennd1a |
DENN/MADD domain containing 1A |
78766 |
0.08 |
chr7_129664007_129664606 | 6.15 |
Gm33248 |
predicted gene, 33248 |
3099 |
0.26 |
chr9_45657127_45657508 | 6.14 |
Dscaml1 |
DS cell adhesion molecule like 1 |
15520 |
0.18 |
chr5_13529208_13529396 | 6.12 |
Gm42676 |
predicted gene 42676 |
3579 |
0.23 |
chr5_112227349_112227837 | 6.06 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
1048 |
0.39 |
chr10_71667175_71667371 | 6.04 |
Gm34544 |
predicted gene, 34544 |
3642 |
0.2 |
chr16_44661031_44661409 | 6.03 |
Nepro |
nucleolus and neural progenitor protein |
63081 |
0.1 |
chr16_37927274_37927446 | 6.03 |
Gpr156 |
G protein-coupled receptor 156 |
10864 |
0.17 |
chr13_39823707_39823913 | 6.02 |
A230103O09Rik |
RIKEN cDNA A230103O09 gene |
544 |
0.74 |
chr10_8391284_8391494 | 6.01 |
Ust |
uronyl-2-sulfotransferase |
89147 |
0.09 |
chr6_28396691_28396863 | 6.01 |
Zfp800 |
zinc finger protein 800 |
1228 |
0.37 |
chr2_21010157_21010628 | 6.00 |
Gm13375 |
predicted gene 13375 |
41338 |
0.14 |
chr5_146384860_146385320 | 5.99 |
Wasf3 |
WAS protein family, member 3 |
105 |
0.97 |
chr7_82872320_82872576 | 5.99 |
Mex3b |
mex3 RNA binding family member B |
5115 |
0.17 |
chr9_23378360_23378672 | 5.99 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr1_81593373_81593581 | 5.98 |
Gm6198 |
predicted gene 6198 |
35994 |
0.2 |
chr12_7029541_7029692 | 5.98 |
Gm46311 |
predicted gene, 46311 |
62656 |
0.16 |
chr2_51753056_51753280 | 5.95 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr6_144251546_144251744 | 5.94 |
Sox5 |
SRY (sex determining region Y)-box 5 |
42077 |
0.21 |
chr15_45730683_45730836 | 5.93 |
Gm2203 |
predicted gene 2203 |
231767 |
0.02 |
chr14_29029040_29029191 | 5.92 |
Lrtm1 |
leucine-rich repeats and transmembrane domains 1 |
8243 |
0.2 |
chr3_98211633_98211906 | 5.89 |
Reg4 |
regenerating islet-derived family, member 4 |
10387 |
0.15 |
chr4_126648482_126648847 | 5.88 |
Gm12933 |
predicted gene 12933 |
16590 |
0.13 |
chr13_15602594_15602999 | 5.87 |
Gm48343 |
predicted gene, 48343 |
47139 |
0.16 |
chr3_127387010_127387518 | 5.84 |
Gm42969 |
predicted gene 42969 |
6442 |
0.16 |
chr2_65415400_65415551 | 5.83 |
Gm24138 |
predicted gene, 24138 |
39193 |
0.13 |
chr8_125226975_125227173 | 5.82 |
Gm16237 |
predicted gene 16237 |
249 |
0.95 |
chr10_56839597_56839798 | 5.81 |
Gm31931 |
predicted gene, 31931 |
10390 |
0.27 |
chr2_91327817_91328355 | 5.81 |
Gm13787 |
predicted gene 13787 |
16103 |
0.14 |
chr4_5962884_5963179 | 5.80 |
Gm11797 |
predicted gene 11797 |
106843 |
0.07 |
chr7_79517996_79518207 | 5.80 |
Gm37608 |
predicted gene, 37608 |
1219 |
0.25 |
chr2_136759053_136759378 | 5.80 |
Gm14053 |
predicted gene 14053 |
14600 |
0.21 |
chr1_132200708_132201234 | 5.79 |
Lemd1 |
LEM domain containing 1 |
8 |
0.96 |
chr12_97978039_97978364 | 5.78 |
Gm35326 |
predicted gene, 35326 |
105681 |
0.06 |
chrX_84076768_84076943 | 5.78 |
Dmd |
dystrophin, muscular dystrophy |
206 |
0.96 |
chr10_91881593_91881813 | 5.76 |
Gm31592 |
predicted gene, 31592 |
7126 |
0.31 |
chr14_75566269_75566669 | 5.76 |
Cby2 |
chibby family member 2 |
25480 |
0.19 |
chr3_157321061_157321436 | 5.75 |
Gm22458 |
predicted gene, 22458 |
44750 |
0.14 |
chr16_81284960_81285127 | 5.75 |
Gm49555 |
predicted gene, 49555 |
5119 |
0.27 |
chrX_12873292_12873455 | 5.71 |
Gm25063 |
predicted gene, 25063 |
3011 |
0.26 |
chr11_34112866_34113040 | 5.68 |
4930469K13Rik |
RIKEN cDNA 4930469K13 gene |
14399 |
0.18 |
chr4_140246501_140247112 | 5.67 |
Igsf21 |
immunoglobulin superfamily, member 21 |
22 |
0.98 |
chr1_47164093_47164266 | 5.67 |
Gm28826 |
predicted gene 28826 |
10718 |
0.28 |
chr2_33812630_33813034 | 5.65 |
Nron |
non-protein coding RNA, repressor of NFAT |
6973 |
0.22 |
chr14_85507558_85507784 | 5.64 |
Gm9264 |
predicted gene 9264 |
28645 |
0.26 |
chr8_7440241_7440417 | 5.64 |
Gm26427 |
predicted gene, 26427 |
12001 |
0.26 |
chr3_18189926_18190086 | 5.64 |
Gm23686 |
predicted gene, 23686 |
12381 |
0.23 |
chr5_20056133_20056284 | 5.63 |
Gm23570 |
predicted gene, 23570 |
36407 |
0.2 |
chr14_31131923_31132463 | 5.63 |
Nt5dc2 |
5'-nucleotidase domain containing 2 |
842 |
0.44 |
chr19_33326930_33327081 | 5.62 |
Rnls |
renalase, FAD-dependent amine oxidase |
65260 |
0.11 |
chr1_41605098_41605443 | 5.60 |
Gm28634 |
predicted gene 28634 |
75727 |
0.12 |
chr3_134331628_134331802 | 5.60 |
Gm43558 |
predicted gene 43558 |
25577 |
0.15 |
chr17_70633998_70634208 | 5.60 |
Dlgap1 |
DLG associated protein 1 |
72551 |
0.1 |
chr5_84848501_84849167 | 5.59 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr3_94484401_94484863 | 5.59 |
Celf3 |
CUGBP, Elav-like family member 3 |
261 |
0.81 |
chr18_71975481_71975670 | 5.59 |
Dcc |
deleted in colorectal carcinoma |
375442 |
0.01 |
chr4_72384278_72384573 | 5.59 |
Gm11235 |
predicted gene 11235 |
158241 |
0.04 |
chr12_85619875_85620071 | 5.58 |
Jdp2 |
Jun dimerization protein 2 |
17751 |
0.14 |
chr15_26275989_26276253 | 5.58 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
32927 |
0.23 |
chr17_47687946_47688804 | 5.56 |
Tomm6 |
translocase of outer mitochondrial membrane 6 |
11 |
0.87 |
chrX_85526285_85526607 | 5.56 |
Tab3 |
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
47576 |
0.14 |
chr6_78245260_78245429 | 5.55 |
Gm5576 |
predicted pseudogene 5576 |
29466 |
0.21 |
chr13_54788797_54789586 | 5.54 |
Tspan17 |
tetraspanin 17 |
186 |
0.91 |
chr17_66761615_66761827 | 5.54 |
Gm49939 |
predicted gene, 49939 |
17160 |
0.14 |
chr11_35527923_35528248 | 5.52 |
Slit3 |
slit guidance ligand 3 |
16600 |
0.26 |
chr13_77490089_77490263 | 5.52 |
Gm9634 |
predicted gene 9634 |
64197 |
0.14 |
chr16_64069361_64069662 | 5.51 |
Gm49627 |
predicted gene, 49627 |
114381 |
0.07 |
chr11_112869991_112870994 | 5.51 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
45313 |
0.16 |
chr8_57922585_57922771 | 5.50 |
Gm45633 |
predicted gene 45633 |
30935 |
0.19 |
chr13_28768739_28768909 | 5.50 |
Mir6368 |
microRNA 6368 |
57951 |
0.11 |
chr11_71758404_71758886 | 5.50 |
Wscd1 |
WSC domain containing 1 |
7269 |
0.18 |
chr12_70367356_70367615 | 5.50 |
Trim9 |
tripartite motif-containing 9 |
19871 |
0.17 |
chr1_9127833_9128130 | 5.49 |
Gm37629 |
predicted gene, 37629 |
64135 |
0.12 |
chr7_144133020_144133171 | 5.49 |
Gm44999 |
predicted gene 44999 |
22010 |
0.2 |
chr15_40533683_40533834 | 5.48 |
Gm7382 |
predicted gene 7382 |
3563 |
0.28 |
chr19_26844786_26845745 | 5.47 |
4931403E22Rik |
RIKEN cDNA 4931403E22 gene |
21358 |
0.18 |
chr16_74397266_74397471 | 5.46 |
Robo2 |
roundabout guidance receptor 2 |
13544 |
0.25 |
chr16_42575508_42575977 | 5.46 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.7 | 8.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.7 | 8.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.6 | 5.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.3 | 9.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
2.3 | 9.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.2 | 6.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.1 | 6.3 | GO:0048880 | sensory system development(GO:0048880) |
2.0 | 6.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.8 | 5.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.8 | 5.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.6 | 4.9 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.5 | 4.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.4 | 4.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.4 | 5.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.4 | 4.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 5.4 | GO:0061743 | motor learning(GO:0061743) |
1.3 | 6.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 10.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.2 | 3.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.2 | 9.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.2 | 3.5 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 6.7 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.1 | 3.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 3.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.1 | 3.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.1 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.0 | 5.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.0 | 4.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 6.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.0 | 2.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.0 | 2.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.0 | 3.9 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.0 | 2.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 2.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.9 | 7.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.9 | 5.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.9 | 7.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 2.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.9 | 1.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 9.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 2.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 2.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 3.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.8 | 2.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 4.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.8 | 1.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.8 | 2.4 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.8 | 4.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.8 | 2.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 4.0 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.8 | 2.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 2.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.8 | 3.8 | GO:0021764 | amygdala development(GO:0021764) |
0.8 | 3.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.8 | 2.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 2.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.7 | 0.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.7 | 3.6 | GO:0031223 | auditory behavior(GO:0031223) |
0.7 | 6.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 5.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.7 | 1.4 | GO:0061551 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trigeminal ganglion development(GO:0061551) facioacoustic ganglion development(GO:1903375) |
0.7 | 4.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.7 | 1.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.7 | 3.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 2.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 2.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.7 | 2.1 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 6.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.7 | 10.1 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.7 | 1.3 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.6 | 10.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 1.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 3.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.6 | 4.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.6 | 1.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 4.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.6 | 1.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.6 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 4.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.6 | 6.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.6 | 8.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.6 | 3.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 4.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.6 | 1.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.6 | 1.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 4.5 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.6 | 2.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.5 | 2.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 2.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 1.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 0.5 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.5 | 1.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 1.1 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.5 | 5.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.5 | 1.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 1.5 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.5 | 2.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.5 | 1.0 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.5 | 1.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 7.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 2.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 2.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 8.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 1.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 1.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.5 | 2.4 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.5 | 2.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 1.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 9.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 3.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.5 | 0.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 0.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 1.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 4.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.4 | 1.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 3.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 2.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 0.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.4 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 0.9 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 4.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 1.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.4 | 1.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 1.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 2.1 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 5.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 2.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 1.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.4 | 2.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 1.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 3.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.4 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 1.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.2 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 1.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.4 | 1.6 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 1.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 0.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 0.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 0.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.4 | 2.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.4 | 3.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 5.1 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.4 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 0.4 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.4 | 1.8 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.4 | 1.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 1.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 0.7 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.4 | 1.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 1.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 1.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 1.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 1.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 1.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 3.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 3.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.3 | 0.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.3 | 1.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.3 | 4.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 2.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 3.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.3 | 1.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 0.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.3 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 1.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 13.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.3 | 0.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.3 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.3 | 0.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 3.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 2.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 1.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 0.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.3 | 1.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 2.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 0.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 2.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 0.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 3.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 1.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 11.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.3 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 0.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 0.8 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 0.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 0.8 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 0.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.3 | 1.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 5.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 2.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 1.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 2.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.5 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.3 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 1.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 1.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 1.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 0.8 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 3.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.2 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.2 | 0.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.5 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.7 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 2.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 1.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 4.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.4 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.2 | 0.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.2 | 0.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 2.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.4 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 4.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 1.5 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 1.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 1.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 4.0 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 0.4 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.2 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 3.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.4 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 3.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.9 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 0.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 0.2 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 2.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 0.7 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.4 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 2.7 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.7 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.2 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.2 | 0.8 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.2 | 0.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.2 | 0.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.8 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.2 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 2.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.6 | GO:0043584 | nose development(GO:0043584) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 1.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.9 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 3.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.5 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.5 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.6 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 1.7 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.1 | 0.6 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.5 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 1.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 1.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 1.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 2.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 1.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.1 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.1 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.1 | 1.3 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 0.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 1.0 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 1.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.6 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 2.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 1.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 2.9 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 1.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 1.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 2.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0060681 | ureteric bud elongation(GO:0060677) branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.1 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.1 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.1 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.1 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.4 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.7 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.4 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 1.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 1.2 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.2 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 2.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.2 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.5 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.1 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.2 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.0 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.2 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.0 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.0 | 0.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.0 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.0 | 0.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.0 | 0.0 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.0 | 0.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 12.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.4 | 7.1 | GO:0097441 | basilar dendrite(GO:0097441) |
1.8 | 5.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.4 | 5.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.2 | 4.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.2 | 8.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.1 | 9.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 3.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 8.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 3.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.8 | 4.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 6.7 | GO:0097449 | astrocyte projection(GO:0097449) |
0.6 | 1.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.6 | 4.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.6 | 3.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 15.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 2.2 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 3.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 3.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 5.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 1.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 8.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 3.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 4.0 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 19.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 3.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 5.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 4.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 7.2 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 1.9 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 2.2 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 3.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 3.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 2.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 1.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 1.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 1.2 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 3.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 2.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 2.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.4 | 2.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 3.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 1.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 7.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 4.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 1.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 3.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 5.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 1.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 2.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 0.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 3.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 1.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 5.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 3.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 2.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 22.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 4.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 6.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 2.0 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.9 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 3.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 10.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 6.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 3.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.1 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 2.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 3.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 1.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 9.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.6 | 7.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.3 | 9.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.8 | 5.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.7 | 12.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.7 | 5.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.6 | 6.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 5.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 5.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.3 | 6.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.2 | 3.6 | GO:0051373 | FATZ binding(GO:0051373) |
1.2 | 3.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 5.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 3.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.9 | 7.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.9 | 3.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 5.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 2.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 2.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.8 | 3.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 4.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.8 | 6.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.8 | 3.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 2.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.8 | 2.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.7 | 1.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.7 | 6.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 1.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 2.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 7.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 0.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 2.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 5.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 2.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 3.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 9.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.5 | 10.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 9.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.5 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 9.3 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 2.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 2.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 3.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.5 | 1.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 1.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 1.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.5 | 1.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.5 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 2.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 4.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 1.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 2.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 1.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 0.8 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 1.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 1.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.4 | 2.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 6.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 5.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 2.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 2.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 6.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 2.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 2.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 7.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 3.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 4.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.5 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 3.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 3.8 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 1.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.1 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 3.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 3.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 1.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 3.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 2.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 1.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 1.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 4.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 2.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 3.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 2.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 4.0 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 2.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 2.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 2.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 3.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 3.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 2.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.6 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 1.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 2.9 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 11.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 2.7 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 4.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.3 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 1.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.0 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 24.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 10.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 4.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 4.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 5.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 5.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 19.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 13.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 1.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.9 | 9.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.9 | 9.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 10.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 13.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.7 | 15.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 18.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 4.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 1.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 2.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 6.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 4.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 3.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 2.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 3.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 0.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 3.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 6.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 2.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 2.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 3.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.6 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.3 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 3.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 4.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 3.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 1.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 1.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.0 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |